ROBERT LANGE ELLIOTT, M.D.
Radiology at Medical Center Dr, Baton Rouge, LA
License number
Louisiana MD.03326R
Category
Radiology
Type
Surgical Oncology
Address
Address
17050 Medical Center Dr STE 400, Baton Rouge, LA 70816
Phone
(225) 755-3070
(225) 755-3085 (Fax)
(225) 755-3085 (Fax)
Personal information
See more information about ROBERT LANGE ELLIOTT at radaris.comName
Address
Phone
500 Haynes Dr, Deridder, LA 70634
516 E Flrnoy Lucas Rd Apt 206A, Shreveport, LA 71115
4595 Highway 849, Grayson, LA 71435
Professional information
Dr. Robert L Elliott, Baton Rouge LA - MD (Doctor of Medicine)
Specialties:
General Surgery
Address:
Elliott Mastology Center
17050 Medical Center Dr SUITE 400, Baton Rouge 70816
(225) 755-3070 (Phone)
17050 Medical Center Dr SUITE 400, Baton Rouge 70816
(225) 755-3070 (Phone)
Procedures:
Biopsy of Breast, Breast Reconstruction, Dressing and/or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy), Excision of Breast Tumor, Lymph Node Biopsy or Excision, Mastectomy, Port Placements or Replacements
Conditions:
Breast Cancer, Breast Lump/Mass, Carcinoma in Situ, Intestinal Obstruction, Lung Cancer, Secondary Malignancies
Certifications:
General Surgery, 1968
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Elliott Mastology Center
17050 Medical Center Dr SUITE 400, Baton Rouge 70816
Ochsner Medical Center - Baton Rouge
17000 Medical Center Dr, Baton Rouge 70816
17050 Medical Center Dr SUITE 400, Baton Rouge 70816
Ochsner Medical Center - Baton Rouge
17000 Medical Center Dr, Baton Rouge 70816
Education:
Medical School
Univ Of Ms Sch Of Med
Graduated: 1961
U Miss Hosp
Wash U Med Ctr
Univ Of Ms Sch Of Med
Graduated: 1961
U Miss Hosp
Wash U Med Ctr
Robert Lange Elliott, Baton Rouge LA
Specialties:
Surgeon
Address:
17050 Medical Center Dr, Baton Rouge, LA 70816
Education:
Doctor of Philosophy
University of Mississippi, School of Medicine - Doctor of Medicine
University of Mississippi Medical Center - Residency - Surgery
University of Mississippi Medical Center - Residency - Thoracic Surgery
University of Mississippi, School of Medicine - Doctor of Medicine
University of Mississippi Medical Center - Residency - Surgery
University of Mississippi Medical Center - Residency - Thoracic Surgery
Board certifications:
American Board of Surgery Certification in Surgery
Robert Lange Elliott, Baton Rouge LA
Specialties:
Surgery, Surgical Oncology
Work:
Breast Clinic
17050 Medical Center Dr, Baton Rouge, LA 70816
17050 Medical Center Dr, Baton Rouge, LA 70816
Education:
University of Mississippi(1961)
Lubricating Oil Composition
US Patent:
4891145, Jan 2, 1990
Filed:
Jan 29, 1986
Appl. No.:
6/823678
Inventors:
Ramah J. Brod - Marcham, Nr. Abingdon, GB
Robert D. Tack - Oxford, GB
Kenneth Lewtas - Wantage, GB
Robert L. Elliott - Baton Rouge LA
Robert D. Tack - Oxford, GB
Kenneth Lewtas - Wantage, GB
Robert L. Elliott - Baton Rouge LA
Assignee:
Exxon Chemical Patents Inc. - Linden NJ
International Classification:
C10M14538
US Classification:
252 52A
Abstract:
The invention concerns a lubricating oil containing less than 3 wt. % of a mixture of (1) a lubricating oil pour depressant and (2) a polyoxyalkylene ester, ether, ester/ether or mixture thereof containing one or more C. sub. 10 to C. sub. 30 alkyl groups and polyoxyalkylene glycol group of molecular weight 100 to 5000, the alkylene group of said polyoxyalkylene glycol containing from 1 to 4 carbon atoms. The pour depressant can for example be a vinyl acetate copolymer, a polyalkylacrylate, a polyalkylmethacrylate or an esterified olefin/maleic anhydride copolymer.
Vaccination Of Cancer Patients
US Patent:
2012028, Nov 8, 2012
Filed:
Jan 13, 2011
Appl. No.:
13/005984
Inventors:
Jonathan F. Head - Baton Rouge LA, US
Robert L. Elliott - Baton Rouge LA, US
Robert L. Elliott - Baton Rouge LA, US
Assignee:
OncBioMune, L.L.C. - Baton Rouge LA
International Classification:
A61K 38/20, A61P 35/00, A61P 35/02, A61P 37/04
US Classification:
424 852
Abstract:
Pharmaceutical compositions containing (i) whole autologous cancer cells, whole allogeneic cancer cells, or a combination thereof; (ii) a colony stimulating factor (CSF); (iii) an interleukin; and (iv) a pharmaceutically acceptable carrier are described which are useful for inhibiting tumor growth, progression or recurrence or to inhibit metastases formation in solid cancerous tumors, leukemias, and lymphomas.
Vaccination Of Cancer Patients Using Tumor-Associated Antigens Mixed With Interleukin-2 And Granulocyte-Macrophage Colony Stimulating Factor
US Patent:
5478556, Dec 26, 1995
Filed:
Feb 28, 1994
Appl. No.:
8/202516
Inventors:
Robert L. Elliott - Baton Rouge LA
Jonathan F. Head - Baton Rouge LA
Jonathan F. Head - Baton Rouge LA
International Classification:
A61K 4505, A61K 3900, C07K 14535, C07K 1455
US Classification:
424852
Abstract:
A breast cancer vaccine which comprises a mixture of tumor associated antigens (TAA) with low doses of recombinant interleukin-2 (IL-2) and granulocyte-macrophage colony stimulating factor (GM-CSF).
Taxane- And Taxoid-Protein Compositions
US Patent:
2011019, Aug 4, 2011
Filed:
Jan 31, 2011
Appl. No.:
13/017173
Inventors:
Jonathan F. Head - Baton Rouge LA, US
Robert L. Elliott - Baton Rouge LA, US
Robert L. Elliott - Baton Rouge LA, US
Assignee:
ONCBIOMUNE, L.L.C. - Baton Rouge LA
International Classification:
A61K 38/38, A61K 38/02, A61K 38/40, A61K 38/22, A61K 38/18, A61P 35/00, A61P 35/02
US Classification:
514 96, 514 11, 514 152, 514 153, 514 115
Abstract:
Compositions comprising a taxane or taxoid, such as paclitaxel, and a protein, such as albumin or a metal-transferrin, such as gallium-transferrin, can be prepared by combining an aqueous protein solution with a second solution containing the taxane or taxoid, a non-ionic surfactant, and an alcohol; adjusting the pH of the combined solutions to between about 7.9 and about 8.3; and purifying the pH-adjusted solution to remove solutes having a molecular weight less than 10,000 Da. Such compositions can be prepared that are substantially free of non-ionic surfactants, such as Cremophor EL, and are useful in the treatment of cancers, such as breast cancer.
Method For Selectively Culturing Epithelial Or Carcinoma Cells
US Patent:
2006003, Feb 16, 2006
Filed:
Aug 16, 2004
Appl. No.:
10/918741
Inventors:
Jonathan Head - Baton Rouge LA, US
Robert Elliott - Baton Rouge LA, US
Robert Elliott - Baton Rouge LA, US
International Classification:
C12N 5/08, C12N 5/02
US Classification:
435383000, 435366000
Abstract:
A method for selectively growing epithelial cells or carcinoma cells in vitro without fibroblast overgrowth comprises (a) suspending a cell pellet comprising digested epithelial or carcinoma cells in a first growth medium, the medium comprising D-valine MEM, methyl cellulose, fetal serum, glutamine and an antibiotic; wherein the methyl cellulose is present in the medium at a concentration sufficient to inhibit growth of fibroblast cells present in the cell pellet; (b) adding the suspension to a cell culture vessel comprising an inner surface which has been at least partially coated with an attachment medium comprising a protein extract, D-valine MEM, glutamine and an antibiotic; and (c) incubating the suspension in the coated vessel to allow selective growth of the epithelial cells or carcinoma cells.
Copolymerisation Of Unsaturated Esters
US Patent:
5179182, Jan 12, 1993
Filed:
May 30, 1990
Appl. No.:
7/532105
Inventors:
Ramah J. Brod - Marcham, GB
Robert L. Elliott - Baton Rouge LA
Jean P. P. Coquerel - Waterloo, BE
Robert L. Elliott - Baton Rouge LA
Jean P. P. Coquerel - Waterloo, BE
Assignee:
Exxon Research & Engineering - Florham Park NJ
International Classification:
C08F 428
US Classification:
526227
Abstract:
The reaction cycle time for the copolymerization of unsaturated esters such as alkyl fumarates and vinyl acetate, and for the polymerization of methacrylates and acrylates may be dramatically reduced by carrying out the polymerization at elevated temperatures and pressures. An additional feature is the addition of initiator during polymerization which leads to improved products especially for lubricating oil pour depressants and fuel and crude oil flow improvers.
Composition For A Cancer Vaccine
US Patent:
8647627, Feb 11, 2014
Filed:
Jan 13, 2011
Appl. No.:
13/005993
Inventors:
Jonathan F. Head - Baton Rouge LA, US
Robert L. Elliott - Baton Rouge LA, US
Robert L. Elliott - Baton Rouge LA, US
Assignee:
OncBioMune, L.L.C. - Baton Rouge LA
International Classification:
A61K 39/00, A61K 38/00, A61K 38/19
US Classification:
4241841, 514 193
Abstract:
Pharmaceutical compositions useful as vaccines are described containing a purified surface or excreted protein qualitatively or quantitatively associated with a type of cancer, at least one interleukin (IL), and at least one colony stimulating factor (CSF), where the purified surface or excreted protein is provided in an amount sufficient to induce an immune response in an individual administered the composition. Such compositions can be used in methods for treating individuals having cancer, and for inducing an immunotherapeutic response in the same.